Scientific article
English

Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates

Published in

Bioorganic & medicinal chemistry letters, vol. 26, no. 1, p. 154-159

Publication date

2016

Abstract

Conditions for the metathesis of alkenes in the convergent synthesis of HDAC inhibitors have been improved by continuous catalyst flow injection in the reaction media. Intermediate and target compounds obtained were tested for their ability to induce HDAC inhibition and tubulin acetylation, revealing the key role of the tert-butyloxycarbonyl (BOC) group for more HDAC6 selectivity. Molecular modelling added rationale for this BOC effect.

Keywords

  • Alkenes/chemistry
  • Benzamides/chemistry
  • Dose-Response Relationship
  • Drug
  • Formic Acid Esters/chemistry
  • Histone Deacetylase Inhibitors/chemistry/pharmacology
  • Histone Deacetylases/metabolism
  • Humans
  • Hydroxamic Acids/chemistry
  • Models
  • Molecular
  • Molecular Structure
  • Structure-Activity Relationship

Citation (ISO format)

ZWICK, Vincent et al. Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates. In: Bioorganic & medicinal chemistry letters, 2016, vol. 26, n° 1, p. 154–159. doi: 10.1016/j.bmcl.2015.11.011

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0960-894X
541views
0downloads

Technical informations

Creation

13/06/2017 21:35:00

First validation

13/06/2017 21:35:00

Update

15/03/2023 01:47:33

Status update

15/03/2023 01:47:33

Last indexation

31/10/2024 07:12:50
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated